BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chemudupati M, Kenney AD, Smith AC, Fillinger RJ, Zhang L, Zani A, Liu SL, Anderson MZ, Sharma A, Yount JS. Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes. J Virol 2020;94:e00326-20. [PMID: 32461320 DOI: 10.1128/JVI.00326-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Laliotis GI, Kenney AD, Chavdoula E, Orlacchio A, Kaba A, La Ferlita A, Anastas V, Tsatsanis C, Beane JD, Sehgal L, Coppola V, Yount JS, Tsichlis PN. Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positive intronless gene mRNAs and sensitivity to viral infection. Commun Biol 2021;4:1179. [PMID: 34635782 DOI: 10.1038/s42003-021-02668-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Reinold J, Farahpour F, Schoerding A, Fehring C, Dolff S, Konik M, Korth J, van Baal L, Buer J, Witzke O, Westendorf AM, Kehrmann J. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients. Front Cell Infect Microbiol 2022;12:848650. [DOI: 10.3389/fcimb.2022.848650] [Reference Citation Analysis]
3 Chen J, Vitetta L. Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19. J Clin Med 2021;10:2903. [PMID: 34209870 DOI: 10.3390/jcm10132903] [Reference Citation Analysis]
4 Korsten SGPJ, Peracic L, van Groeningen LMB, Diks MAP, Vromans H, Garssen J, Willemsen LEM. Butyrate Prevents Induction of CXCL10 and Non-Canonical IRF9 Expression by Activated Human Intestinal Epithelial Cells via HDAC Inhibition. IJMS 2022;23:3980. [DOI: 10.3390/ijms23073980] [Reference Citation Analysis]
5 López-Hernández Y, Monárrez-Espino J, Oostdam AH, Delgado JEC, Zhang L, Zheng J, Valdez JJO, Mandal R, González FLO, Moreno JCB, Trejo-Medinilla FM, López JA, Moreno JAE, Wishart DS. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci Rep 2021;11:14732. [PMID: 34282210 DOI: 10.1038/s41598-021-94171-y] [Reference Citation Analysis]
6 Akhmedov VA. Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19. Terapevticheskii arkhiv 2022;94:277-82. [DOI: 10.26442/00403660.2022.02.201388] [Reference Citation Analysis]
7 Sencio V, Machelart A, Robil C, Benech N, Hoffmann E, Galbert C, Deryuter L, Heumel S, Hantute-Ghesquier A, Flourens A, Brodin P, Infanti F, Richard V, Dubuisson J, Grangette C, Sulpice T, Wolowczuk I, Pinet F, Prévot V, Belouzard S, Briand F, Duterque-Coquillaud M, Sokol H, Trottein F. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters. Gut Microbes 2022;14:2018900. [PMID: 34965194 DOI: 10.1080/19490976.2021.2018900] [Reference Citation Analysis]
8 Yang M, Yang Y, He Q, Zhu P, Liu M, Xu J, Zhao M. Intestinal Microbiota-A Promising Target for Antiviral Therapy? Front Immunol 2021;12:676232. [PMID: 34054866 DOI: 10.3389/fimmu.2021.676232] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Rocha J, Basra T, El Kurdi B, Venegas-Borsellino C. Effects of Potential Micro- and Macro-nutrients in Combatting COVID-19. Curr Surg Rep 2021;9:24. [PMID: 34484977 DOI: 10.1007/s40137-021-00301-w] [Reference Citation Analysis]
10 Liu TFD, Philippou E, Kolokotroni O, Siakallis G, Rahima K, Constantinou C. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review. Infection 2021. [PMID: 34671922 DOI: 10.1007/s15010-021-01715-5] [Reference Citation Analysis]
11 Rowe HM, Rosch JW. Polymicrobial Interactions Operative during Pathogen Transmission. mBio 2021;12:e01027-21. [PMID: 34006664 DOI: 10.1128/mBio.01027-21] [Reference Citation Analysis]
12 Dowling JW, Forero A. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions. J Immunol 2022;208:247-56. [PMID: 35017214 DOI: 10.4049/jimmunol.2100707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Wirusanti NI, Baldridge MT, Harris VC. Microbiota regulation of viral infections through interferon signaling. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.007] [Reference Citation Analysis]
14 Chac D, Bhuiyan TR, Saha A, Alam MM, Salma U, Jahan N, Chowdhury F, Khan AI, Ryan ET, LaRocque R, Harris JB, Qadri F, Weil AA. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine. Infect Immun 2021;89:e0021721. [PMID: 34228490 DOI: 10.1128/IAI.00217-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schlatterer K, Peschel A, Kretschmer D. Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections? Front Cell Infect Microbiol 2021;11:785833. [PMID: 34926327 DOI: 10.3389/fcimb.2021.785833] [Reference Citation Analysis]
16 Woods Acevedo MA, Pfeiffer JK. Microbiota-immune system interactions and enteric virus infection. Curr Opin Virol 2021;46:15-9. [PMID: 32898729 DOI: 10.1016/j.coviro.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Pascoal LB, Rodrigues PB, Genaro LM, Gomes ABDSP, Toledo-Teixeira DA, Parise PL, Bispo-Dos-Santos K, Simeoni CL, Guimarães PV, Buscaratti LI, Elston JGA, Marques-Souza H, Martins-de-Souza D, Ayrizono MLS, Velloso LA, Proenca-Modena JL, Moraes-Vieira PMM, Mori MAS, Farias AS, Vinolo MAR, Leal RF. Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples. Gut Microbes 2021;13:1-9. [PMID: 33550892 DOI: 10.1080/19490976.2021.1874740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]